News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
News Conference News TCT 2019 TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients Todd Neale October 03, 2019
News Conference News TCT 2019 GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients? Todd Neale September 30, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News Conference News TCT 2019 TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events Yael L. Maxwell September 26, 2019
News Conference News TCT 2017 Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors Todd Neale October 30, 2017
News Conference News TCT 2015 TUXEDO-India Affirms Superiority of EES in Patients With Diabetes Todd Neale October 14, 2015
News Conference News TCT 2015 Experts Debate Optimal Pharmacologic Approach for STEMI Patients October 11, 2015
News Conference News TCT 2014 PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI September 15, 2014
News Conference News TCT 2013 Studies Find Differing Benefits of Platelet, Genotype Testing October 31, 2013